1. Pretransplantation Consolidation Chemotherapy Decreases Leukemia Relapse after Autologous Blood and Bone Marrow Transplants for Acute Myelogenous Leukemia in First Remission 
Martin S. Tallman, Waleska S. Pérez, Hillard M. Lazarus, Robert Peter Gale, Richard T. Maziarz, Jacob M. Rowe, David I. Marks, Jean- Yves Cahn, Asad Bashey, Michael R. Bishop, Neal Christiansen, Stanley R. Frankel, Juan J. García, Osman Ilhan, Mary J. Laughlin, Jane Liesveld, Charles Linker, Mark R. Litzow, Selina Luger, Philip L. McCarthy, Gustavo A. Milone, Santiago Pavlovsky, Gordon L. Phillips, James A. Russell, Ruben A. Saez, Gary Schiller, Jorge Sierra, Roy S. Weiner, Axel R. Zander, Mei-Jie Zhang, Armand Keating, Daniel J. Weisdorf, Mary M. Horowitz 
Biology of Blood and Marrow Transplantation 
Volume 12, Issue 2, Pages (February 2006)
DOI: /j.bbmt
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidences of TRM (A) and relapse (B) after autologous bone marrow (BM) or PBSC transplantation for AML in first CR by pretransplantation cytarabine consolidation therapy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Adjusted probabilities of LFS (A) and overall survival (B) after autologous bone marrow (BM) or PBSC transplantation for AML in first CR by cytarabine pretransplantation consolidation therapy.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions